Clarke v. Healthsouth Corporation

CourtDistrict Court, M.D. Florida
DecidedJanuary 14, 2021
Docket8:14-cv-00778
StatusUnknown

This text of Clarke v. Healthsouth Corporation (Clarke v. Healthsouth Corporation) is published on Counsel Stack Legal Research, covering District Court, M.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Clarke v. Healthsouth Corporation, (M.D. Fla. 2021).

Opinion

UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA TAMPA DIVISION

DARIUS CLARKE, M.D., et al.,

Plaintiffs,

v. Case No. 8:14-cv-778-T-33AAS

HEALTHSOUTH CORPORATION, et al.,

Defendants. _____________________________/

ORDER This matter comes before the Court upon consideration of Defendants HealthSouth Corporation and Rehabilitation Hospital Corporation of America, LLC’s Motion to Exclude Expert Testimony, filed on August 27, 2020. (Doc. # 184). Plaintiffs Darius Clarke, M.D., and Restorative Health and Wellness, PLLC responded on September 10, 2020. (Doc. # 186). For the reasons that follow, the Motion is granted in part and denied in part. I. Background In the instant action, Dr. Clarke and Restorative Health and Wellness (a professional limited liability company wholly owned and operated by Dr. Clarke) (collectively, “Dr. Clarke”) seek relief against Dr. Clarke’s former employer — Rehabilitation Hospital Corporation of America — and its owner — HealthSouth Corporation — (collectively “HealthSouth”) under the anti-retaliation provision of the False Claims Act (FCA), 31 U.S.C. § 3730(h). (Doc. # 139). Dr. Clarke began working for HealthSouth in February 2009 as an attending physician and medical director. (Id. at ¶ 16). According to Dr. Clarke, while at HealthSouth he discovered that HealthSouth was fraudulently manipulating admissions procedures to maintain “Intermediate Rehabilitation Facility” (IRF) status for its hospitals. (Id. at ¶ 34). Dr. Clarke

alleges that once he discovered these fraudulent practices, the “specter of civil or criminal liability” forced him to resign in August 2010. (Id. at ¶¶ 59, 62-63). Dr. Clarke identifies two main activities that allegedly compelled him to quit. First, Dr. Clarke claims HealthSouth frequently pressured staff to use the diagnosis of “disuse myopathy” (DM) to qualify patients as appropriate for IRF care. (Id. at ¶¶ 39, 41-45). According to Dr. Clarke, DM is a completely fictitious disease, and this pressure led to inappropriate patients being admitted to HealthSouth. (Id.). Second, Dr. Clarke claims that clinical liaison Susan Habenicht would inappropriately “shop around” patients. (Id.

at ¶¶ 57-58). According to Dr. Clarke, after he denied a patient, Habenicht would present the same patient to alternate physicians who would “almost always admit the patient that Dr. Clarke deemed, or would have deemed, to be inappropriate for [admission].” (Id. at ¶ 53). Dr. Clarke claims that because of these practices, he was “faced with a choice of either continuing to work in an environment in which the law was being violated on a daily basis, and being complicit in these crimes, or to end the relationship [with HealthSouth].” (Id. at ¶¶ 59, 62, 63). Therefore, his voluntary termination in August 2010 was a

“constructive discharge” in violation of 31 U.S.C. §3730(h). As part of discovery, Clarke retained Suzanne Groah, M.D., “as an expert witness qualified to opine with regard to whether HealthSouth’s practices, viewed objectively, were fraudulent or unlawful, and intolerable to any physician and medical director of an IRF in the position of Dr. Clarke.” (Doc. # 186 at 3). Dr. Groah has worked as an attending physician at several inpatient rehabilitation hospitals. (Doc. # 184-3 at 17:25- 18:14). Although Dr. Groah has never worked as a medical director at an inpatient rehabilitation hospital (Id.), she is currently the Chief of the Paralysis, Rehabilitation, and

Recovery Program at National Rehabilitation Hospital in Washington, DC. (Id. at 12:10-13:11; Doc. # 184-1 at 2). She has also taught rehabilitation medicine at Georgetown University since 2005. (Doc. # 184-1 at 3). Based on her experience as a rehabilitation physician, Dr. Groah concludes in her expert report: A reasonable physician would find any one of numerous adverse conditions and actions that Dr. Darius Clarke was experiencing at HealthSouth Corporation n/k/a Encompass Health Corporation to be professionally intolerable. These adverse conditions and actions include those events described in paragraphs 1 through 11 below and can be summarized as follows: non-clinical management directing admissions personnel to avoid presenting cardiac, pulmonary and low-functioning patients to Dr Clarke for admission; non-clinical management applying pressure to admit patients not suitable for inpatient rehabilitation; non-clinical management applying pressure to use improper diagnoses to justify admissions; and non-clinical management applying pressure to retain patients when discharge was clinically indicated.

(Doc. # 184-2 at 1).

In reaching this conclusion, Dr. Groah also opines that: (1) DM is not an “accepted diagnosis used in medical rehabilitation;” (2) HealthSouth “knowingly made fraudulent claims;” and (3) that HealthSouth staff “circumvent[ed]” Dr. Clarke when admitting patients. (Id. at 1, 4-5). HealthSouth moves to exclude this testimony, arguing that (1) the testimony offers nothing more than what counsel can argue to the jury; (2) Dr. Groah did not apply a reliable methodology to reach her conclusion; (3) Dr. Groah is not qualified to offer an opinion on what is “professionally intolerable.” (Doc. # 184). Dr. Clarke has responded. (Doc. # 186) and the Motion is ripe for review. For the reasons below, the Motion is granted in part and denied in part. II. Legal Standard Federal Rule of Evidence 702 states: A witness who is qualified as an expert by knowledge, skill, experience, training, or education may testify in the form of an opinion or otherwise if: (a) the expert’s scientific, technical, or other specialized knowledge will help the trier of fact to understand the evidence or to determine a fact in issue; (b) the testimony is based on sufficient facts or data; (c) the testimony is the product of reliable principles and methods; and (d) the expert has reliably applied the principles and methods to the facts of the case.

Fed. R. Evid. 702. Implementing Rule 702, Daubert v. Merrell Dow Pharms., Inc., 509 U.S. 579 (1993), requires district courts to ensure that any and all scientific testimony or evidence admitted is both relevant and reliable. See Id. at 589–90. Such Daubert analysis also applies to non-scientific expert testimony. Kumho Tire Co. v. Carmichael, 526 U.S. 137, 147 (1999). District courts must conduct this gatekeeping function “to ensure that speculative, unreliable expert testimony does not reach the jury under the mantle of reliability that accompanies the appellation ‘expert testimony.’” Rink v. Cheminova, Inc., 400 F.3d 1286, 1291 (11th Cir. 2005). In determining whether an expert opinion is admissible, the district court must assess whether: (1) the expert is qualified to testify competently regarding the matters he intends to address; (2) the methodology by which the expert reaches his conclusions is sufficiently reliable as determined by the sort of inquiry mandated in Daubert; and (3) the testimony assists the trier of fact, through the application of scientific, technical, or specialized expertise, to understand the evidence or to determine a fact in issue.

Hendrix v. Evenflo Co., 609 F.3d 1183

Free access — add to your briefcase to read the full text and ask questions with AI

Related

City of Tuscaloosa v. Harcros Chemicals, Inc.
158 F.3d 548 (Eleventh Circuit, 1998)
United States v. Richard Junior Frazier
387 F.3d 1244 (Eleventh Circuit, 2004)
Rink v. Cheminova, Inc.
400 F.3d 1286 (Eleventh Circuit, 2005)
Louise Cook v. Sheriff of Monroe County
402 F.3d 1092 (Eleventh Circuit, 2005)
Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Kumho Tire Co. v. Carmichael
526 U.S. 137 (Supreme Court, 1999)
Hendrix Ex Rel. Gp v. Evenflo Co., Inc.
609 F.3d 1183 (Eleventh Circuit, 2010)
Levin v. Dalva Brothers, Inc.
459 F.3d 68 (First Circuit, 2006)
Karla Robinson v. Geico General Insurance Company
447 F.3d 1096 (Eighth Circuit, 2006)
Kidder, Peabody & Co. v. IAG International Acceptance Group
14 F. Supp. 2d 391 (S.D. New York, 1998)
Wolf v. MWH Constructors, Inc.
34 F. Supp. 3d 1213 (M.D. Florida, 2014)
Leathers v. Pfizer, Inc.
233 F.R.D. 687 (N.D. Georgia, 2006)
Clena Investments, Inc. v. XL Specialty Insurance
280 F.R.D. 653 (S.D. Florida, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Clarke v. Healthsouth Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/clarke-v-healthsouth-corporation-flmd-2021.